Breathe Well Live Well
|
/ CORRECTION – Emmy(R) Award Winning Actor Bryan Cranston Hosts Will Rogers …
MarketWatch (press release) BURBANK, CA — September 20, 2011 — The Will Rogers Institute has released a new PSA campaign that highlights the danger signs and health risks associated with asthma. The campaign, featuring Emmy(R) award winning actor Bryan Cranston, informs viewers … |
View full post on asthma – Google News
|
Asthma Therapeutics – Pipeline Assessment and Market Forecasts to 2018
MarketWatch (press release) 20, 2011 /PRNewswire via COMTEX/ — Reportlinker.com announces that a new market research report is available in its catalogue: GlobalData, the industry analysis specialist, has released its new report, "Asthma Therapeutics – Pipeline Assessment and … Asthma Therapeutics – Pipeline Assessment and Market Forecasts to 2018 Asthma Therapeutics – Pipeline Assessment and Market Forecasts to 2018 |
View full post on asthma – Google News
|
Emmy(R) Award Winning Actor Bryan Cranston Hosts Will Rogers Institute's PSA …
MarketWatch (press release) BURBANK, CA, Sep 20, 2011 (MARKETWIRE via COMTEX) — The Will Rogers Institute has released a new PSA campaign that highlights the danger signs and health risks associated with asthma. The campaign, featuring Emmy(R) award winning actor Bryan Cranston, … |
View full post on asthma – Google News
|
Study: Latinos Face Major Health Risks from Delays of EPA Air Pollution Rules
MarketWatch (press release) As of 2008, 4.7 million Hispanics had been diagnosed with asthma. In their lifetime, Latinos are three times more likely to die from asthma than other racial or ethnic groups. Exposure to air pollution can aggravate preexisting health problems … Study to Show Half of Hispanic Americans are at Risk From Breathing Unhealthy air |
View full post on asthma – Google News
|
Trident Pharmaceuticals Announces Initiation of Phase 1a Clinical Study of HF1020
MarketWatch (press release) HF1020 is believed to offer a novel approach for treating the underlying inflammatory pathology of autoimmune disease and allergic asthma, without causing systemic immunosupression. HF1020 is an oral biopharmaceutical product which acts by inducing … |
View full post on asthma – Google News
|
Azma.com Launches New Features to Help Asthma Sufferers
MarketWatch (press release) PLYMOUTH MEETING, Pa., Sep 15, 2011 (BUSINESS WIRE) — Azma.com is launching enhanced site content that will help asthma sufferers take control of and manage their condition. The enhancements include better-organized content to help users quickly find … |
View full post on asthma – Google News
|
AB Science Announces That FDA Authorization (IND) Has Been Granted for the …
MarketWatch (press release) For the record, severe persistent asthma uncontrolled with oral corticosteroids is a disease that has no registered treatment and all the immunosuppressant and biologic drugs tested to date have failed. Masitinib is therefore the only drug candidate in … |
View full post on asthma – Google News
|
Planet People and Allergy & Asthma Network Mothers of Asthmatics Warn of Mold …
MarketWatch (press release) TORONTO, Sep 14, 2011 (BUSINESS WIRE) — September is National Mold Awareness Month, and Planet People, a manufacturer of innovative, sustainable cleaning products, and the Allergy & Asthma Network Mothers of Asthmatics (AANMA) are educating consumers … |
View full post on asthma – Google News
|
Asthma Society of Canada Partners With PatientOrderSets.com to Deliver Asthma …
MarketWatch (press release) TORONTO, ONTARIO, Sep 12, 2011 (MARKETWIRE via COMTEX) — The Asthma Society of Canada and PatientOrderSets.com are proud to announce a partnership to deliver specialized asthma education materials through PatientOrderSets.com's national network of … |
View full post on asthma – Google News
|
Asmacure Ltee to Present at the 2011 BioPharm America Conference
MarketWatch (press release) 1, 2011 /PRNewswire via COMTEX/ — Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin Driscoll … |
View full post on asthma – Google News